Evidence map›Paper›PMID 35082324›Full record

ArticleScientific reports2022

Potential antitumor and anti-inflammatory activities of an extracellular polymeric substance (EPS) from Bacillus subtilis isolated from a housefly.

Lingxiu Zhang, Huilan Yi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Synbiotic ofJournal of microbiology and biotechnology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Antimicrobial Potential of the GeneraAntibiotics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lingxiu ZhangSchool of Life Science, Shanxi University, No. 92 Wucheng Road, Taiyuan, 030006, China.ORCID 0000-0003-0232-4001
Huilan YiSchool of Life Science, Shanxi University, No. 92 Wucheng Road, Taiyuan, 030006, China. yihl@sxu.edu.cn.ORCID 0000-0002-9298-8313
Shanxi University · CN

Funding

Key Research and Development Plan of Shanxi Province No. 201903D421062National Science Foundation of China No.31972132
6 · The paper itself

Abstract

Bacillus subtilis, a probiotic, has been applied in the medical, food, and feed industries among others. However, the mechanisms of its benefits to hosts are not yet fully understood. Here the characterization and bioactivities of an extracellular polymeric substance (EPS) from Bacillus subtilis were investigated to reveal its partial mechanisms and provide the theoretical basics for further development and utilization of Bacillus subtilis. In this study, the novel strain Bacillus subtilis xztubd1 (GenBank: MG458322.1) was isolated from a housefly's body, identified according to phenotypical and genotypical analyses, and found to produce large amounts of an EPS. Through ultraviolet spectroscopy and Fourier transform infrared spectroscopy (FTIR spectroscopy), the EPS was found to contain a variety of chemical functional groups, such as O-H groups, C=C, C=O, CH

Indexed as

AnimalsAnimals, Outbred StrainsAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsBacillus subtilisCell ProliferationExtracellular Polymeric Substance MatrixHeLa CellsHousefliesHumansInterleukin-2MacrophagesMaleMiceMuramidaseAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsexopolysaccharide, BacillusInterleukin-2MuramidasePolysaccharides, Bacterial

Identifiers

PMID35082324
PMCPMC8791979
OpenAlexW4210773718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.